A Rare Uterine Mass-case Report

Similar documents
Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

One of the commonest gynecological cancers,especially in white Americans.

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

What is endometrial cancer?

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Staging and Treatment Update for Gynecologic Malignancies

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Article begins on next page

Tips, Tricks & Controversies in Laparoscopic Hysterectomy. No disclosures. Keys to success. Learning Objectives

Tissue Morcellation: Managing Risks to Drive Best Patient Outcomes

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Case Scenario 1. History

improved with an MIS approach. This clinical benefit for American women has been demonstrated with Level I evidence. Hysterectomy is one of the most

Vaginal intraepithelial neoplasia

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Endometrial Stromal Sarcoma

Facing Gynecologic Surgery?

Cervical cancer presentation

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Kieran Sultan, PGY4 Penrose St. Francis Hospital

Case Report Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor

UTERINE LEIOMYOSARCOMA. About Uterine leiomyosarcoma

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

X-Plain Ovarian Cancer Reference Summary

JMSCR Vol 05 Issue 06 Page June 2017

JMSCR Volume 03 Issue 01 Page January 2015

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

Hysterectomy. What is a hysterectomy? Why is hysterectomy done? Are there alternatives to hysterectomy?

Atlas Of Gynecologic Surgical

C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

M of initial surgical treatment of cancer of

Cervical Cancer: 2018 FIGO Staging

Hysterectomy : A Clinicopathologic Correlation

Case Report Leiomyosarcoma of the Vagina: An Exceedingly Rare Diagnosis

Monica Dandapani, 1 Brandon-Luke L. Seagle, 1 Amer Abdullah, 1 Bryce Hatfield, 2 Robert Samuelson, 1 and Shohreh Shahabi 3. 1.

Gynecological Cancers

CASE STUDY. Presented by: Jessica Pizzo. CFCC Sonography student Class of 2018

Citation 泌尿器科紀要 (1981), 27(11):

Key words: Adenocarcinoma, Adenomyosis, Biopsy, Ovary, Small Cell Lung Carcinoma.

Endometrial Cancer. Incidence. Types 3/25/2019

reproductive organs. Malignant neoplasms. 4. Inflammatory disorders of female reproductive organs 2 5. Infertility. Family planning.

Histopathological Study of Spectrum of Lesions Seen in Surgically Resected Specimens of Fallopian Tube

Gynaecological Oncology Cases

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

MEMORANDUM. TO: Sandy Koufax FROM: Martin A. Ginsburg, BSN, RN SUBJECT: Merit Screen Johns DATE: 23SEP16. Mr. Koufax,

PRIMARY ADENOCARCINOMA OF THE FALLOPIAN TUBE - A CASE REPORT

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

PORTEC-4. Patient seqnr. Age at inclusion (years) Hospital:

Facing a Hysterectomy? If you ve been diagnosed with gynecologic cancer, learn about minimally invasive da Vinci Surgery

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Consent Advice No. XX (Joint with BSGE) Peer Review Draft Spring Morcellation for Laparoscopic Myomectomy or Hysterectomy

Clear cell carcinoma arising from abdominal wall endometriosis: a unique case with bladder and lymph node metastasis

FDG-PET/CT in Gynaecologic Cancers

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Disclosure. Case. Mixed Tumors of the Uterine Corpus and Cervix. I have nothing to disclose

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Molly A. Brewer DVM, MD, MS Chair and Professor Department of Obstetrics and Gynecology University of Connecticut School of Medicine


C ORPUS UTERI C ARCINOMA STAGING FORM (Carcinosarcomas should be staged as carcinomas)

Aulia Rahman, S. Ked Endang Sri Wahyuni, S. Ked Nova Faradilla, S. Ked

Endometrial line thickness in different conditions.

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Title: Linitis plastica of the colon due to metastases of invasive lobular breast carcinoma

Types of Hysterectomy for Non-cancerous Conditions: Understanding Your Doctor s Recommendations

A Rare Case of Invasive Squamous Cell Carcinoma of Cervix Extending to Endometrium and Right Fallopian Tube

Sara Schaenzer Grand Rounds January 24 th, 2018

Pre-operative assessment of patients for cytoreduction and HIPEC

A Case Report Hydronephrosis and Hydrodureter due to Ureteral Deep Infiltrating Endometriosis mimic Ureteral Stricture Suryamanggala SI 1, Satria ML 2

UTERINE SARCOMAS CURRENT THERAPEUTIC OPTIONS

IMS QUIZ on Perimenopausal Bleeding, Bangalore Menopause Society marks

Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma

Metastatic Colonic Adenocarcinoma Simulating Primary Ovarian Neoplasm in Transvaginal Doppler Sonography

Use of Power Morcellators: Minimizing Liability, Assuring Safety? By Barbara Youngberg

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Vagina. 1. Introduction. 1.1 General Information and Aetiology

Prof. Dr. Aydın ÖZSARAN

SCAR ENDOMETRIOSIS: CASE REPORT Onimi Syamala 1, G. Usha Rani 2

Gynecologic Malignancies. Kristen D Starbuck 4/20/18

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

A case of pedunculated intraperitoneal leiomyoma

Uterine Mesenchymal Tumors from a Gynaecological Point of View: A Mini-Review

Cervix Carcinoma Case: Metastatic

Uterine sarcoma. Information for patients Gynaecology

Laparoscopy for 10cm fibroid. Dr Jim Tsaltas Head of Monash Endosurgery Unit Clinical Director Melbourne IVF

Quiz. b. 4 High grade c. 9 Unknown

Laparoscopy-Hysteroscopy

2016 Uterine Cancer Annual Report

Endometriosis of the Appendix Resulting in Perforated Appendicitis

Pathway Gynaecology Cancer & Diagnostic Protocol for Inter Trust transfer

NEOPLASIA-I CANCER. Nam Deuk Kim, Ph.D.

CA125 in the diagnosis of ovarian cancer: the art in medicine

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

Dr Samuel Soo Advanced Laparoscopic Gynaecological Surgeon Obstetrician & Gynaecologist Fertility & IVF

Index. B Bilateral salpingo-oophorectomy (BSO), 69

Transcription:

Indian Journal of Science and Technology A Rare Uterine Mass-case Report N. Hephzibah Kirubamani 1* and Shruthi Kamal 2 1 Professor, Obstetrics & Gyneacology, Saveetha Medical college- Saveetha University, Chennai. 2 Professor, Surgery, Saveetha Medical college- Saveetha University, Thandalam, Chennai, Tamil Nadu, 602 105; shruthivenkat2002@yahoo.co.in Abstract Fibroids, also known as leiomyomas, are the most common benign uterine neoplasms. Although benign, they can undergo malignant transformation. Metastatic breast cancer is rarely identified in a uterine leiomyoma. Herein we are reporting a case of a 52-year postmenopausal patient who presented with rapidly increasing huge abdominal mass with a size that was almost reaching xipisternum. She underwent modified radicalmastectomy for infiltracting intraductalcarrcinoma two years ago and was tamoxifen since then. After investigation like abdominal and Pelvic USG,C.T abdomen suggested Leiomyosarcoma and subtotal hysterectomy was done due to technical difficulty. Pathological analysis revealed metasatic lobular breast carcinoma involving the uterine fundus and leiomyoma. This case is reported for its rarity, as Metastasis of extragenital neoplasms to the uterus is extremely rare and lobular breast cancer metastasizing to a leiomyoma in a patient using tamoxifen. Keywords: Uterine Mass, Metatasizing to Leiomyoma, Lobular Cancer of Leiomyoma. 1. Introduction Leiomyoma is the commonest benign uterine neoplasm. Sarcoma is the most common malignant change in fibroid. Uterine metastases from extragenital cancer are rarely reported. More frequently, the female genital tract is a direct extension from an adjacent pelvic organ. Breast cancer is the most common malignant disease in women, accounting for 192 370 cases in 2009 in the United States [1]. However, breast cancer metastating to the female genital tract is rather uncommon; when this occurs, the ovaries are usually involved [2, 3]. Similarly, Metastasis to the uterus has been identified in patients with a history of infiltrating lobular carcinoma of the breast [3, 6]. Through this case and review of literature we want to high light clinical and histological aspects of this rare pathology. 2. Case Report We report a case of 52-year-old postmenopausal women who was referred from department of general surgery to gynaec outpatient department for a rapidly growing palpable mass abdomen up to xiphisternum. (Figure 1) The patient had no bowel disturbance and Micturation was normal. There were no pressure symptoms. The patient underwent Modified Radical Mastectomy for infiltrating ductal carcinoma of the right breast two years ago (Figure 1) and she was taking Tamoxifen since then and during her follow up abdominal USG revealed fibroid and she was advised hysterectomy about one and half years ago but the patient did not come for further follow- up. Physical examination revealed an obese woman with thyroid and other breast clinically normal. Vitals were stable. Per abdominal examination revealed a huge hard mass filling the entire abdomen arising from pelvic mass but no ascities. No organomegaly. Per vaginal examination revealed cervix hitched against pubic symphysis, Movement of cervix transmitted to mass in the abdomen. Speculum examination cervix normal. Routine laboratory investigations were normal, Abdominal and Pelvic USG (Figure 2 )shows large sized heterogenous mass arising from uterus with some changes * Corresponding author: N. Hephzibah Kirubamani (hepsi1002@yahoo.co.in)

N. Hephzibah Kirubamani and Shruthi Kamal 4325 near fundus suggestive of Leiomyoma with sarcomatous changes, both ovaries normal. No evidence of Ascities. Right side hydronephrosis. C.T Abdomen and pelvis reveled heterogeneous mass arising from uterus, both ovaries normal, no ascities, few Ext iliac nodes were present, suggestive of Leiomyoma with sarcomatous changes. Hence Provisional clinical diagnosis of Leomyosarcoma was made. Endometrial scrapping nil, Cervix- normal. PapSmear report - Inflammatory. Ureteric stent was placed before exploratory Laparotomy and it revealed the presence of irregularly enlarged uterus about 34-36 weeks one more fibroid about 6cm in the lower part of the uterus close to bladder, no Ascities (Figure 3). Both ovaries were normal and were laterally placed. Saline washing was sent for Cytological examination. Myomectomy followed by subtotal hysterectomy was done since there was another fibroid near bladder (Figure 4, 5 & 6). As there was generalized ooze and patient general condition was not satisfactory, internal iliac artery ligation was carried out. Patient was given 3 units of blood on the table and also given with post- operative 3units of blood with FFP in 3 units. On 12th post- operative day, patient developed sub- acute intestinal obstruction due to adhesions and later had an abdominal wall dehiscence. She was taken up for relook laparotomy and bowel resection anastomosis, infracolic omentectomy was done and sent for HPE. The peritoneal and skin edges were trimmed and sutured. She had uneventful postoperative recovery and was discharged on 24 th day and sent for chemotherapy since pathologic analysis revealed metastatic lobular breast carcinoma involving the uterine fundus and a leiomyoma. (Figure 7). 3. Discussion Figure 1. Huge abdominal mass with previous modified radical mastectomy scar. Metastasis of extragenital neoplasms to the uterus is extremely rare. For Lobular breast cancers, the chance to metastasize the uterus is more than the ductal carcinomas, but they metastasize as tiny nodules that can be missed with the standard diagnostic workup. Here we report a case of lobular breast cancer metastasizing to a leiomyoma in a patient using Tramoxifen. Metastatic breast cancer occurs via lymphatic involvement, hematogeneous dissemination, and contiguous Figure 2. Abdominal USG shows huge fibroid changes near fibroid.

4326 A Rare Uterine Mass - Case Report Figure 3. Peroperative findings. Figure 5. Myomectomy specimen. Figure 4. Myomectomy proceed with subtotal hysterectomy. spread [5]. When the process is manifested, pulmonary, hepatic, and bone are the most common distal sites. If the gynecologic tract is involved, lobular carcinoma is more likely the source of the metastasis, rather than ductal carcinoma [6, 7]. One interesting aspect of our report is the metastatic breast cancer which has invaded the uterine myoma alone with no invasion of surrounding structures. There was no evidence of widespread disease and metastatic involvement but only within the uterus and Leiomyoma. Omentum specimen showed no evidence of malignancy: Ascitic fluid is negative for malignancy. Rest of the viscera is normal. Figure 6. Subtotal hysterectomy specimen. The other interesting fact we report is that infiltrating ductal breast carcinoma metastasizing on a uterine Leiomyoma, which is similar to earlier report [11]. Yasuhara et al. [11] described an advanced invasive ductal breast carcinoma in a patient who exhibited coexistent metastatic foci within a uterine leiomyosarcoma. Approximately, 22 cases of metastatic breast cancer that infiltrated a uterine Leiomyoma have been reported [8, 9, 10].

N. Hephzibah Kirubamani and Shruthi Kamal 4327 Figure 7. Histopathology examination shows Metastatic lobular breast carcinoma involving the uterine fundus and a leiomyoma (-cohesive cells individually dispersed or arranged in single- file linear patterns, Indian files). However, when the leiomyosarcoma was initially diagnosed at imaging, the metastatic disease had yet to be identified. In another case study, Minelli et al. [8] reported a 37- year- old patient with a uterine wall myoma and hypermenorrhea. After surgical removal of the uterine myoma and pathologic review, a diagnosis of metastatic carcinoma of breast origin was made [4]. Histologic review of breast cancer subtypes also suggests that lobular carcinoma has a propensity for genital tract infiltration, predominantly in patients positive for hormone receptor [12, 13]. 4. Conclusion This entity can be confused clinically with a leiomyosarcoma. Growth of leiomyomas under aromatase inhibitors should be considered as a sign of metastases and surgery can be planned in selected cases. 5. Acknowledgement The authors thank Chancellor, Pro- chancellor, Director & Dean, of Saveetha Medical college for the encouragement and for giving permission to report the case. We would like to thank profusely Prof. Shruthi Kamal Prof of Surgery for the help and support to manage the case. We also thank sincerely Assistant surgeons Dr. Anupama, Dr. Padmabharathi and Anestheology Department for their earnest service. 6. References 1. American Cancer Society (2009). Cancer Facts & Figures, Atlanta, GA. 2. Pauer H U, Viereck V et al. (2003). Uterine cervical metastasis of breast cancer: a rare complication that may be overlooked, Onkologie, vol 26(1), 58 60. 3. Scopa C D, Aletra C, et al. (2005). Metastases of breast carcinoma to the uterus: report of two cases, one harboring a primary endometrioid carcinoma, with review of the literature. Gynecologic Oncology, vol 96(2), 543 547. 4. Kumar N B, and Hart W R (1982). Metastases to the uterine corpus from extragenital cancers: a clinicopathologic study of 63 cases. Cancer, vol 50(10), 2163 2169. 5. Metser U, Haider M A et al. (2003). MR imaging findings and patterns of spread in secondary tumor involvement of the uterine body and cervix. American Journal of Roentgenology, vol 180(3), 765 769. 6. Borst M J, and Ingold J A (1993). Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery, vol 114(4), 637 641. 7. Lamovec J, and Bracko M (1991). Metastatic pattern of infiltrating lobular carcinoma of the breast: an autopsy study. Journal of Surgical Oncology, 48: 28 33. 8. Minelli L, Romagnolo C, et al. (1998). Uterine leiomyoma metastasis as a first sign of breast cancer, The Journal of the American Association of Gynecologic Laparoscopists, vol 5(2), 213 215. 9. Beattie G J, Duncan A J, et al. (1993). Breast carcinoma metastatic to uterine leiomyoma, Gynecologic Oncology, vol 51(2), 255 257.

4328 A Rare Uterine Mass - Case Report 10. Sugiyama T, Toyoda N et al. (1995). Breast cancer metastatic to uterine leiomyoma: a case report, The Journal of Obstetrics and Gynaecology Research, vol 21(4), 349 355. 11. Yasuhara Y, Mikami Y et al. (2008). Metastatic breast carcinoma identified in a uterine leiomyosarcoma, Pathology International, vol 58(5), 317 321. 12. Kondo N I, Yoshida S et al. (2009). Metastasis of breast cancer to a uterine leiomyoma, Breast Cancer, vol 16(2), 157 161. 13. Piura B, Yanai- Inbar I et al. (1999). Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy, European journal of obstetrics, gynecology, and reproductive biology, vol 83(1), 57 61.